Search

everythinglearnresearchcommunity

for

Search:↓

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Hair loss is a common side effect of hormone treatments for cancer.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Lasers are effective and safe for various medical treatments, including cancer, wound healing, and skin conditions.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.